The meta-regression also demonstrated a marginally significant relative risk of 1.13 (95% CrI 0.99–1.26) of SVR12 versus SVR24.
← all excerpts
SVR12 is higher than SVR24 in treatment-naïve hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.
2
—
—
The sentences
That is, the Bayesian meta-regression provided marginally statistically significant evidence that the SVR12 is, on average, 13% relatively higher than SVR24.